Invesco Ltd. Sells 259,880 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Invesco Ltd. reduced its stake in Pediatrix Medical Group, Inc. (NYSE:MD) by 24.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 790,112 shares of the company’s stock after selling 259,880 shares during the period. Invesco Ltd. owned approximately 0.92% of Pediatrix Medical Group worth $10,366,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Barclays PLC increased its stake in Pediatrix Medical Group by 302.9% during the 3rd quarter. Barclays PLC now owns 142,087 shares of the company’s stock valued at $1,646,000 after purchasing an additional 106,817 shares in the last quarter. Geode Capital Management LLC raised its holdings in Pediatrix Medical Group by 2.4% in the 3rd quarter. Geode Capital Management LLC now owns 1,936,751 shares of the company’s stock worth $22,452,000 after acquiring an additional 45,155 shares during the last quarter. Franklin Resources Inc. bought a new position in Pediatrix Medical Group in the 3rd quarter valued at approximately $598,000. Principal Financial Group Inc. increased its holdings in shares of Pediatrix Medical Group by 14.1% in the 3rd quarter. Principal Financial Group Inc. now owns 513,618 shares of the company’s stock worth $5,953,000 after purchasing an additional 63,581 shares in the last quarter. Finally, Everence Capital Management Inc. raised its stake in shares of Pediatrix Medical Group by 7.5% in the fourth quarter. Everence Capital Management Inc. now owns 13,840 shares of the company’s stock worth $182,000 after purchasing an additional 960 shares during the last quarter. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Stock Performance

MD opened at $12.14 on Wednesday. The company’s 50 day moving average is $14.15 and its 200 day moving average is $13.97. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. The company has a market cap of $1.04 billion, a price-to-earnings ratio of -10.12, a PEG ratio of 1.74 and a beta of 1.32. Pediatrix Medical Group, Inc. has a 12-month low of $6.62 and a 12-month high of $17.67.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings results on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.12. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The business had revenue of $502.36 million for the quarter, compared to analysts’ expectations of $486.22 million. On average, equities research analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on MD shares. StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 22nd. UBS Group increased their price objective on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a research report on Friday, February 21st. Finally, Truist Financial cut their target price on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating for the company in a research report on Friday, April 11th. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $16.75.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.